RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Jaffetilchin Investment Partners, LLC's Holding History (CIK: 0001404652)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 30,401 Value ($000) $154 Avg Close $4.91 Range $3.79 - $6.11

Q4 2024

Shares 21,754 Value ($000) $147 Avg Close $6.72 Range $5.60 - $9.55

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	30,401	$154	$4.91	$3.79 - $6.11
Q4 2024	21,754	$147	$6.72	$5.60 - $9.55